Artificial Intelligence
Medical Imaging Market Generate Revenue Of $48.8 Billion (+CAGR Of 5.4%) Worldwide by 2032 – Exclusive Report By Market.us
<!– Name:DistributionId Value:8841205 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2790 –> <!– Name:CustomerId Value:1269133 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:b4daf4a1-0b37-4b2e-8026-a8c31c0393dd –>
New York, May 17, 2023 (GLOBE NEWSWIRE) — The medical imaging market size is expected to be worth around USD 48.8 Bn by 2032 from USD 29.2 Bn in 2022, growing at a CAGR of 5.4% during the forecast period from 2022 to 2032.
Medical imaging techniques help in the visualization of body organs internally, allowing better care for patients. It is an essential component of the healthcare industry meant for better diagnosis and to contribute to treatment planning.
Detail Insights on the impact of each segment and make informed business decisions. Request for Sample @ https://market.us/report/medical-imaging-market/request-sample/
Key Takeaway:
- By type, the X-ray segment dominated the market with the largest revenue share in 2022.
- By applications, the orthopedic segment held the largest market share globally.
- By end-user, the hospital’s segment accounted for a significant revenue share of the total market in 2022.
- In 2022, North America dominated the market with the highest revenue share of 36.0%.
- Asia-Pacific is expected to be the fastest-growing market from 2023-2032.
The market expansion of medical imaging is mainly influenced due to the factors such as growing demand for early detection tools, growing prevalence of lifestyle-related diseases, rising technological advancements, increased investment as well as reimbursement initiatives undertaken by the various government, as well as expansions of new facilities by major players in emerging countries.
Factors Affecting the Growth of the Global Medical Imaging Market
There are several factors that can affect the growth of the medical imaging market. Some of these factors include:
- Integration of imaging modalities: It is anticipated that the growth of the medical imaging market and also robot-assisted surgery systems will likely benefit from the integration of imaging modalities with advanced surgical suit manufacturers.
- Rising doctor’s preference for AI-based assistance: The increase in awareness of the benefits associated with AI techniques and their wide applications has resulted in the higher implementation of AI in the medical diagnostic sector.
- Rising incidence of chronic diseases: The rising incidence of chronic diseases in emerging economies is expected to offer significant growth opportunities in the near future, which can be highly attributed to market expansion.
- Rising competition: The entry of multinational healthcare service providers is resulting in high competition and high demand for world-class healthcare services. As a result, the market is expected to grow more significantly during the forecast period.
To understand how our report can bring a difference to your business strategy, Inquire about a brochure at https://market.us/report/medical-imaging-market/#inquiry
Top Trends in Global Medical Imaging Market
The rising awareness of the benefits associated with AI techniques and their broad applications has led to the high implementation of AI in the medical diagnostic sector. AI-based medical technologies considerably help doctors and clinicians in their decision-making concerning diagnosis and treatment. Therefore, doctors are more inclined towards the adoption of these near-to-accurate, cost-effective, and safe solutions compared to the traditional ones, which, in turn, propels market growth. As a result, a higher number of market players are involved in partnerships and collaboration to offer advanced technologies to their consumers, thereby fueling market growth.
Market Growth
The market growth can be highly attributed to the increasing aged population, a rise in the cases of chronic diseases, and the growing trend of preventive, diagnostic practices. Moreover, the medical imaging market has witnessed significant growth during the COVID-19 pandemic owing to the importance of medical imaging in the diagnosis and in deciding the treatment of severe COVID-19 infections. However, frequent product recalls in medical imaging equipment are expected to impede market growth.
Regional Analysis
North America accounted as the dominant region in 2022, with the highest revenue share owing to favorable reimbursement policies and funding from major market players. This results in the higher adoption of advanced and high-end medical imaging equipment. Moreover, the growth of the regional market can be attributed to the large number of industry players and the frequent introduction of new products in this region. The Asia Pacific market is anticipated to expand at the fastest CAGR during the forecast period owing to the rising incidence of chronic diseases and the increasing popularity of advanced medical imaging. Additionally, it is anticipated that a growing number of local manufacturing units will likely offer diagnostic units at reasonable prices.
Have Queries? Speak to an expert or Click Here To Download/Request a Sample
Scope of Report
| Report Attribute | Details |
| Market Value (2022) | USD 29.2 Billion |
| Market Size (2032) | USD 48.8 Billion |
| CAGR (from 2023 to 2032) | 5.4% |
| North America Revenue Share | 36.0% |
| Historic Period | 2016 to 2022 |
| Base Year | 2022 |
| Forecast Year | 2023 to 2032 |
Market Drivers
The market for medical imaging has grown as a result of recent innovations and technological advancements. Specialists in the medical field make extensive use of medical imaging techniques for the purpose of diagnosing diseases and providing guidance for treatment. The surgical views provided by the true 3D software help to reduce the occurrence of unexpected situations during the performance of surgeries, helping the surgeons to give precise care to the patient. Better patient care is made possible by breakthrough innovations such as (AI) artificial intelligence and (VR) virtual reality that are combined with three-dimensional imaging, thereby facilitating the expansion of market share. Also, these advancements make disease finding and treatment more favorable by facilitating accurate and early disease detection. Additionally, the new approaches to portable and wearable scanners, nuclear imaging, etc., are predicted to further accelerate the growth of the medical imaging market.
Market Restraints
Frequent product recalls in medical imaging equipment are the major factor predicted to hamper the market growth of medical imaging during the forecast period. This has led to the decreased adoption of innovative and new equipment in several countries. Several domestic and established players have entered the market, offering low-cost and refurbished equipment to global healthcare facilities. This is combined with the presence of largely refurbished equipment in the market, especially in developing markets such as India and China. The overall cost-benefit of these refurbished devices for medium and small-sized healthcare facilities is in a higher ratio, which has resulted in lower adoption.
Market Opportunities
Emerging economies such as China, India, South Korea, Brazil, Russia, Turkey, and South Africa are offering higher growth opportunities for the key market players in the medical imaging market. The rising incidence of chronic diseases such as stroke, cancer, cardiovascular, and neurological diseases, as well as the higher mortality rates in these countries, face the need for early disease detection. Although the cost factor is a major concern in these emerging countries, their large population bases, especially in China and India offer sustainable growth in the market for medical imaging devices.
Grow your profit margin with Market.us – Purchase This Premium Report at https://market.us/purchase-report/?report_id=11771
Report Segmentation of the Medical Imaging Market
Type Insight
The X-ray segment dominated the global medical imaging market in 2022 with a significant revenue share due to the rising utilization of X-rays in diagnostic centers and hospitals. The demand for X-rays is rising due to advancements in DR (digital radiography). X-rays are painless, non-invasive, and take less time, making them ideal for immediate diagnosis and deciding treatment. The CT Scan segment is projected to grow at the fastest CAGR over the forecast period owing to high demand for (POC) point-of-care CT devices and the development of high-precision CT scanners due to the integration of AI & ML as well as advanced visualization systems.
Application Insight
The orthopedics segment dominated the global market for medical imaging in 2022 with a significant portion of the market share and is anticipated to expand potentially over the forecast period. This significant market share can be highly attributed to the rise in medical imaging technologies such as X-rays, MRI, CT scans, and ultrasound, as it plays a crucial role in the diagnosis and treatment of orthopedic conditions such as joint injuries, degenerative bone diseases, and fractures.
End-User Insight
The hospital’s segment is estimated to be the most lucrative segment in the global medical imaging market, with the largest revenue share in 2022. The entry of multinational healthcare service providers is the main reason behind this growth. Additionally, this segment is expected to grow owing to the integration of surgical suits with imaging technologies and the rising demand for advanced imaging modalities. Furthermore, the segment’s growth is anticipated to be fueled by rising competition and rising demand for world-class healthcare services in the coming years.
For more insights on the historical and Forecast global market data from 2016 to 2032 – download a sample report at https://market.us/report/medical-imaging-market/request-sample/
Market Segmentation
By Type
- Ultrasound
- Computed Tomography (CT Scan)
- Magnetic Resonance Imaging (MRI)
- X-Ray
- Other Types
By Application
- Orthopedics
- Neurology
- Cardiology
- Oncology
- Gynecology
- Other Applications
Based on End-User
- Hospitals
- Diagnostic Imaging Centers
- Specialty Clinics
- Other End-Users
By Geography
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Competitive Landscape
The major market players are largely focused on implementing various growth strategies, thereby supporting the market growth of the medical imaging market. The development process is sped up, and market competition is intensified as a result of such collaborations and technology exchanges, resulting in sophisticated but cost-effective imaging systems. In addition, they are involved in increasing investments, mergers & acquisitions, partnerships, and competitive pricing.
The competitive landscape of the market has also been examined in this report. Some of the major players include
- FUJIFILM VisualSonics Inc.
- Koninklijke Philips N.V.
- Siemens Healthcare GmbH
- Mindray Medical International Ltd
- Hologic, Inc.
- Canon Medical Systems Corporation
- Samsung Medison Co., Ltd.
- Cubresa Inc.
- Esaote SpA
- Other Key Players
Recent Development of the Medical Imaging Market
- In April 2022, The next-generation Revolution Aspire CT scanner was launched by Wipro GE Healthcare. It is an advanced imaging solution that is manufactured and designed end-to-end in India.
- In July 2022, The Vantage Fortain MRI System at ECR 2022 was launched by Canon Medical. This MRI system features innovative workflow solutions, accelerated scan technology, and image enhancements, which together contribute to reducing the time required for MRI.
Browse More Related Reports:
About Us:
Market.US (Powered by Prudour Pvt Ltd) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report-providing firm. Market.US provides customization to suit any specific or unique requirement and tailor-makes reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons.
Follow Us On LinkedIn Facebook Twitter
Our Blog:
North America
LONDON, May 1, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT; CLVT PR A) (“Clarivate”), a leading global provider of transformative intelligence, today announced that its board of directors declared a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares (the “Preferred Shares”), payable in cash on June 3, 2024 to shareholders of record at the close of business on May 15, 2024.
On the mandatory conversion date, which is scheduled to occur on June 3, 2024, each Preferred Share will automatically and mandatorily convert into a number of ordinary shares of Clarivate (and cash in lieu of any fractional ordinary shares) based on the average volume weighted average price (“VWAP”) of Clarivate’s ordinary shares over a 30-trading day period that begins on, and includes, April 18, 2024 and is scheduled to end on, and include, May 30, 2024 (the “valuation period”). If such VWAP is (i) greater than $31.20, then the mandatory conversion rate will be 3.2052 ordinary shares of Clarivate per Preferred Share, (ii) less than or equal to $31.20 but equal to or greater than $26.00, then the mandatory conversion rate will be a number of ordinary shares of Clarivate per Preferred Share equal to $100.00 divided by such VWAP and (iii) less than $26.00, then the mandatory conversion rate will be 3.8462 ordinary shares of Clarivate per Preferred Share. The mandatory conversion rate will be announced following the end of the valuation period. The above description of the terms of the Preferred Shares is not complete and is subject to, and qualified in its entirety by reference to, the “Statement of Rights” for the Preferred Shares, which is filed as Exhibit 3.2 to Clarivate’s annual report on Form 10-K for the fiscal year ended December 31, 2023.
Cautionary Note Regarding Forward-Looking Statements
This communication contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future business, events, trends, contingencies, financial performance, or financial condition, appear at various places in this communication and may use words like “aim,” “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “see,” “seek,” “should,” “strategy,” “strive,” “target,” “will,” and “would” and similar expressions, and variations or negatives of these words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on management’s current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include those factors discussed under the caption “Risk Factors” in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). However, those factors should not be considered to be a complete statement of all potential risks and uncertainties. Additional risks and uncertainties not known to us or that we currently deem immaterial may also adversely affect our business operations. Forward-looking statements are based only on information currently available to our management and speak only as of the date of this communication. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, except as otherwise required by securities and other applicable laws. Please consult our public filings with the SEC or on our website at www.clarivate.com.
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clarivate-declares-dividend-on-mandatory-convertible-preferred-shares-302133633.html
BEIJING, May 1, 2024 /PRNewswire/ — Focusing on the development of AI, the third CMG Forum was held on Monday in Beijing.
Li Shulei, a member of the Political Bureau of the Communist Party of China (CPC) Central Committee and the head of the Publicity Department of the CPC Central Committee, attended the opening of the event and delivered a speech.
Guests at the forum stressed the role of media in promoting the innovative application of AI as well as its governance.
Efforts should also be made to boost the development of AI in creating positive, healthy, diverse and high-quality content, so that AI can become a force for good and benefit mankind, they agreed.
They also called on media to accelerate intelligent transformation and help bridge international exchanges and cooperation on the governance of AI to facilitate its healthy, orderly and safe development.
Hosted by China Media Group (CMG), the forum attracted more than 200 participants from international organizations, media, think tanks and multinational companies.
“Innovation and breakthroughs in science and technology not only guide the development and progress of human civilization, but also bring uncertainty to the changing world,” said Shen Haixiong, vice minister of the Publicity Department of the CPC Central Committee and president of CMG. He called for efforts to jointly create valuable and responsible artificial intelligence.
AI technology is affecting every aspect of our lives. Thomas Bach, president of the International Olympic Committee (IOC), stated in a video speech that CMG has always been a partner of the IOC, bringing the charm of the Olympic Games to hundreds of millions of Chinese viewers. He said the IOC invites CMG to work together for the creation of a future with the application of AI in Olympic sports.
“From ancient inventions such as silk, printing and the compass to modern technological advances such as robotics, telecommunications and green technology, China has always been committed to innovation and creation,” said Daren Tang, director general of the World Intellectual Property Organization (WIPO). He said WIPO pays close attention to ensuring a balance between the opportunities and risks of artificial intelligence and is committed to strengthening cooperation to ensure that artificial intelligence is properly used.
https://news.cgtn.com/news/2024-04-30/3rd-CMG-Forum-in-Beijing-discusses-AI-development-1tdDcXvCexG/p.html
View original content:https://www.prnewswire.co.uk/news-releases/cgtn-3rd-cmg-forum-in-beijing-discusses-ai-development-302133410.html
Artificial Intelligence
Trianz Appoints Sridhar Kannan as Practice Leader – Digital, Elevating its Leadership in the Global Digital Transformation Space
SANTA CLARA, Calif., May 1, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Sridhar Kannan as Practice Leader – Digital. With over 25 years of extensive experience in technology and business leadership, Sridhar joins Trianz to lead the expansion of Trianz’s Digital Practice, forging strategic alliances and expanding the business footprint.
Sridhar’s appointment comes at a transformative phase for Trianz as it solidifies its commitment to redefining the digital landscape with an “IP Led” model. This strategic shift is powered by Trianz’s cutting-edge hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace. Sridhar’s visionary leadership in technology-led business transformations across diverse sectors will be instrumental in leveraging IP-led models and innovative methodologies to position Trianz at the forefront of digital transformation.
“We are thrilled to welcome Sridhar Kannan to the Trianz family,” said Seshi Vanguru, Chief Revenue Officer at Trianz. “His appointment marks a significant stride in Trianz’s journey toward innovation and excellence. Sridhar’s wealth of experience and exceptional leadership skills will elevate our Digital Practice to new heights, reaffirming our commitment to delivering exceptional value to our clients.”
Sridhar is recognized as a client-focused technology and business transformation executive with a remarkable track record of helping Banking and Financial Services organizations in business transformation and product innovation using applications, cloud, data, and digital solutions. His extensive prior experience at industry giants such as Wipro, Cognizant, and Infosys include successfully leading Fortune 10 global client relationships and implementing transformative solutions across Banking, Financial Services, and Healthcare industries. Sridhar is highly regarded for his ability to lead global cross-functional teams, foster collaboration, and achieve aggressive business goals while consistently delivering high levels of client satisfaction.
“I am deeply honored to join Trianz and contribute to its mission of shaping the future through digital transformation,” said Sridhar. “Together, we will push the boundaries of what’s possible and drive meaningful impact for our clients in this rapidly evolving digital landscape.”
Based out of Minnesota, US, Sridhar has steered numerous clients towards success through the strategic application of Digital, Cloud, Product Engineering, Data, AI, and Application services, making him a seasoned strategist in today’s dynamic digital landscape. His appointment marks a significant milestone in Trianz’s journey to nurturing talent and delivering world-class solutions.
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our “IP Led Transformations” approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media Team : [email protected]+1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/trianz-appoints-sridhar-kannan-as-practice-leader–digital-elevating-its-leadership-in-the-global-digital-transformation-space-302132835.html
-
Uncategorized6 days agoCherrypicks Partners with AWS DevAx Leading Cloud Technology Innovation for Hong Kong Enterprises
-
Artificial Intelligence6 days agoHikvision redefines urban mobility with AIoT-powered solutions at Intertraffic 2024
-
Artificial Intelligence5 days agoHITACHI ACQUIRES MA MICRO AUTOMATION OF GERMANY IN EFFORT TO ACCELERATE GLOBAL EXPANSION OF ROBOTIC SI BUSINESS IN THE MEDICAL AND OTHER FIELDS
-
Artificial Intelligence6 days agoWeb O.No: Metaverse and Web 3.0 stunted by internet chaos, warn 87% of business leaders
-
Artificial Intelligence6 days ago
Greater efforts urged on sci-tech cooperation
-
Artificial Intelligence5 days agoCognitive Security Market Projected to Reach $134.26 billion by 2030 – Exclusive Report by 360iResearch
-
Uncategorized6 days ago
Xiao-I Corporation to Announce Full Year 2023 Results
-
Artificial Intelligence5 days ago
IBM, Government of Canada, Government of Quebec Sign Agreements to Strengthen Canada’s Semiconductor Industry
